Literature DB >> 17230218

Stem cells transform into a cardiac phenotype with remodeling of the nuclear transport machinery.

Carmen Perez-Terzic1, Randolph S Faustino, Brian J Boorsma, D Kent Arrell, Nicolas J Niederländer, Atta Behfar, Andre Terzic.   

Abstract

Nuclear transport of transcription factors is a critical step in stem cell commitment to a tissue-specific lineage. While it is recognized that nuclear pores are gatekeepers of nucleocytoplasmic exchange, it is unknown how the nuclear transport machinery becomes competent to support genetic reprogramming and cell differentiation. Here, we report the dynamics of nuclear transport factor expression and nuclear pore microanatomy during cardiac differentiation of embryonic stem cells. Cardiac progeny derived from pluripotent stem cells displayed a distinct proteomic profile characterized by the emergence of cardiac-specific proteins. This profile correlated with the nuclear translocation of cardiac transcription factors. The nuclear transport genes, including nucleoporins, importins, exportins, transportins, and Ran-related factors, were globally downregulated at the genomic level, streamlining the differentiation program underlying stem cell-derived cardiogenesis. Establishment of the cardiac molecular phenotype was associated with an increased density of nuclear pores spanning the nuclear envelope. At nanoscale resolution, individual nuclear pores exhibited conformational changes resulting in the expansion of the pore diameter and an augmented probability of conduit occupancy. Thus, embryonic stem cells undergo adaptive remodeling of the nuclear transport infrastructure associated with nuclear translocation of cardiac transcription factors and execution of the cardiogenic program, underscoring the plasticity of the nucleocytoplasmic trafficking machinery in accommodating differentiation requirements.

Entities:  

Mesh:

Year:  2007        PMID: 17230218     DOI: 10.1038/ncpcardio0763

Source DB:  PubMed          Journal:  Nat Clin Pract Cardiovasc Med        ISSN: 1743-4297


  35 in total

Review 1.  Interactome of a cardiopoietic precursor.

Authors:  Randolph S Faustino; Andre Terzic
Journal:  J Cardiovasc Transl Res       Date:  2008-06-03       Impact factor: 4.132

2.  Cardiac transcription factors driven lineage-specification of adult stem cells.

Authors:  Ana Armiñán; Carolina Gandía; José Manuel García-Verdugo; Elisa Lledó; José Luis Mullor; José Anastasio Montero; Pilar Sepúlveda
Journal:  J Cardiovasc Transl Res       Date:  2009-10-21       Impact factor: 4.132

3.  Decoded calreticulin-deficient embryonic stem cell transcriptome resolves latent cardiophenotype.

Authors:  Randolph S Faustino; Anca Chiriac; Nicolas J Niederlander; Timothy J Nelson; Atta Behfar; Prasanna K Mishra; Slobodan Macura; Marek Michalak; Andre Terzic; Carmen Perez-Terzic
Journal:  Stem Cells       Date:  2010-07       Impact factor: 6.277

4.  Interaction of asymmetric ABCC9-encoded nucleotide binding domains determines KATP channel SUR2A catalytic activity.

Authors:  Sungjo Park; Bernard B C Lim; Carmen Perez-Terzic; Georges Mer; Andre Terzic
Journal:  J Proteome Res       Date:  2008-03-01       Impact factor: 4.466

Review 5.  Biology and biophysics of the nuclear pore complex and its components.

Authors:  Roderick Y H Lim; Katharine S Ullman; Birthe Fahrenkrog
Journal:  Int Rev Cell Mol Biol       Date:  2008       Impact factor: 6.813

6.  Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells.

Authors:  Timothy J Nelson; Almudena Martinez-Fernandez; Satsuki Yamada; Carmen Perez-Terzic; Yasuhiro Ikeda; Andre Terzic
Journal:  Circulation       Date:  2009-07-20       Impact factor: 29.690

7.  c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.

Authors:  Almudena Martinez-Fernandez; Timothy J Nelson; Yasuhiro Ikeda; Andre Terzic
Journal:  J Cardiovasc Transl Res       Date:  2010-02       Impact factor: 4.132

8.  Developmental restructuring of the creatine kinase system integrates mitochondrial energetics with stem cell cardiogenesis.

Authors:  Susan Chung; Petras P Dzeja; Randolph S Faustino; Andre Terzic
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

9.  Embryonic stem cell therapy of heart failure in genetic cardiomyopathy.

Authors:  Satsuki Yamada; Timothy J Nelson; Ruben J Crespo-Diaz; Carmen Perez-Terzic; Xiao-Ke Liu; Takashi Miki; Susumu Seino; Atta Behfar; Andre Terzic
Journal:  Stem Cells       Date:  2008-07-31       Impact factor: 6.277

10.  Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells.

Authors:  Clifford D L Folmes; Almudena Martinez-Fernandez; Randolph S Faustino; Satsuki Yamada; Carmen Perez-Terzic; Timothy J Nelson; Andre Terzic
Journal:  J Cardiovasc Transl Res       Date:  2012-12-18       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.